Stimcell EnergeticsSTME -10.29%25 EBIT per Share is $-0.04 as of Feb. 2026. GuruFocus rates STME with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Stimcell Energetics ranks better than 87.39% on this metric.
Stimcell Energetics's EBIT per Share for the
three
months ended in Feb. 2026 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 was $-0.04.
During the past 3 years, the average EBIT per Share Growth Rate was 46.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 41.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 28.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Stimcell Energetics's EBIT per Share or its related term are showing as below:
STME'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -453.6 Med: 16.3 Max: 48.3
Current: 46.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Stimcell Energetics was 48.30% per year. The lowest was -453.60% per year. And the median was 16.30% per year.
STME's 3-Year EBIT Growth Rate is ranked better than 87.39% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs STME: 46.10
Stimcell Energetics (OTCPK:STME) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Stimcell Energetics EBIT per Share Related Terms
Stimcell Energetics EBIT per Share Historical Data
* Premium members only.
The historical data trend for Stimcell Energetics's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stimcell Energetics (STME) has a EBIT per Share of $-0.04 as of Feb. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Stimcell Energetics and its competitors. According to the industry distribution chart, Stimcell Energetics ranks #87 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 12.6%.
Is Stimcell Energetics' EBIT per Share too high?
Stimcell Energetics' current EBIT per Share is $-0.04. Based on the distribution chart, Stimcell Energetics ranks #87 out of 690 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Stimcell Energetics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' EBIT per Share compare to NVNO and TRIB?
According to the Medical Devices & Instruments industry distribution chart, Stimcell Energetics ranks #87 out of 690 companies for EBIT per Share. This places Stimcell Energetics in the top 13% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Stimcell Energetics and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stimcell Energetics's current EBIT per Share is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current EBIT per Share of $-0.04. The current EBIT per Share is $-0.04. Stimcell Energetics' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Stimcell Energetics (STME), the current EBIT per Share is $-0.04 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
25GF Score
Get the complete analysis for STME
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STME has been successfully added to your 
